Form 4: Health In Tech Director William D. Howard Granted Over 128,000 Restricted Shares

Health In Tech, Inc. Director William D. Howard was granted 128,474 shares of Class A Common Stock at $0.62 per share as part of the company's Equity Incentive Plan, with vesting tied to service.

Summary

• William D. Howard, a Director of Health In Tech, Inc. (HIT), acquired 128,474 shares of Class A Common Stock on June 23, 2025.
• The shares were granted as restricted stock under the Health in Tech Equity Incentive Plan.
• The grant price per share was $0.62, totaling an approximate value of $79,653.88.
• The restricted shares are subject to vesting conditions: either fully upon one year of service commencing December 23, 2024, or partially at the first shareholders' meeting based on a pro-rata calculation, contingent on continuous service through the vesting date.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive. The grant of restricted stock to a director is a routine compensation event that aligns interests and incentivizes long-term commitment, which is generally viewed favorably by investors. There are no negative implications or red flags within the filing itself.

Positives

• The grant of restricted stock aligns the director's interests with those of shareholders, as the value of the compensation is tied to the company's stock performance.
• The transaction indicates the company is utilizing its Health in Tech Equity Incentive Plan to compensate its directors, a common practice to attract and retain talent.

Risks

• The vesting of the restricted shares is contingent upon the reporting person's continuous service through the vesting date, meaning the shares could be forfeited if service is terminated prematurely.

Future Outlook

The restricted stock grant implies a future outlook of continued service from Director William D. Howard, with the shares vesting over time, aligning his long-term interests with the company's performance.

Industry Context

This transaction is a standard form of equity compensation for directors in publicly traded companies, aiming to align management and board interests with shareholder value creation. It reflects a common practice within the healthcare technology sector to incentivize long-term commitment.

Comparison to Industry Standards

• The use of restricted stock grants as a component of director compensation is a widely accepted practice across various industries, including healthcare technology, aligning with corporate governance best practices.
• The vesting schedule, tied to a service period, is typical for such grants, similar to compensation structures seen in companies like Teladoc Health or Amwell, which also utilize equity incentives to retain key personnel.

Corporate Governance

Related Party Transactions

• Grant of restricted stock to William D. Howard, a Director of Health In Tech, Inc., as part of the company's established equity incentive plan.

Stakeholder Impact

• Shareholders: The grant of restricted stock can lead to minor dilution but aims to align the director's interests with shareholder value creation.
• Employees: The existence and utilization of an equity incentive plan can signal a commitment to performance-based compensation, potentially impacting employee morale and retention strategies.
• Director (William D. Howard): Receives equity compensation, incentivizing long-term commitment and performance.

Next Steps

• The restricted shares will vest either fully upon one year of service commencing December 23, 2024, or partially at the first shareholders' meeting, subject to continuous service.

Key Dates

Keywords

Health In Tech, HIT, Form 4, Insider Transaction, Restricted Stock, Equity Incentive Plan, Director Compensation, Stock Grant, Beneficial Ownership